4sight Health January 31, 2024
David Burda

It’s that time of year again when I try to educate myself on drugs, drug prices and drug spending. I limit my classes to one day a year lest I get sucked down the rabbit hole of covering big pharma and turn into a one-trick healthcare business journalist pony, murmuring about million-dollar pills in my sleep.

My textbooks are the IQVIA Institute’s annual Global Use of Medicines report and CMS’ annual report on national health expenditures (NHE). IQVIA released the 2024 report earlier this month. CMS released its latest report on historic NHE in December.

Let’s start with a few factoids from CMS, shall we?

  • National health spending on prescription drugs rose 8.4% in 2022 to $405.9 billion.
  • That’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech, Survey / Study, Trends
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article